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Immunization of  mice bearing the nonresponder haplotypes, H-2 ~" q" s. with the 
terpolymer  L-glutamic  acid6°-L-alanine3°-L-tyrosine  TM  (GAT)  1 stimulates  sup- 
pressor T cells (Ts) that specifically inhibit GAT-specific IgG plaque-forming cell 
(PFC)  responses by syngeneic mice to  GAT complexed to  the immunogenic 
carrier methylated bovine serum albumin (GAT-MBSA) in vitro and in vivo (1, 
2). Analogous to the results of Tada and Taraguchi with other systems (3, 4), 
previous  studies  from  our  laboratory  have  shown that  cell-free  extracts  of 
spleens or thymuses from GAT-primed, nonresponder DBA/1  (H-2  Q) or A.SW 
(H-2  "~) mice suppress the PFC responses to GAT-MBSA, but not to sheep red 
blood cells  (SRBC) in the strains of origin  (5). In the previous paper of this 
series,  we have described and evaluated the in vitro assay for the activity of 
GAT-specific suppressive factor,  defined the  activity  of $5o  units/ml  as  the 
inverse of the dilution of the extracts  that cause 50% inhibition of PFC  re- 
sponses, verified the reproducibility of the suppression observed with different 
extracts, and demonstrated that the suppressive factor(s) extracted from lymph- 
oid cells of GAT-primed nonresponder mice is obtained from T cells (6). These 
techniques have permitted an initial characterization of the properties of the 
GAT-specific suppressor T-cell factor (GAT-TsF) in the crude extracts of lymph- 
oid cells from GAT-primed DBA]I mice that is described in this communication. 
Two main issues were then addressed. First, the fine specificity of GAT-T~F was 
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Abbreviations  used in this paper: CFA, complete Freund's adjuvant; GAT, random terpolymer 
of L-glutamic acide°-L~alanine3°-L-tyrosinel°;  GAT-MBSA, GAT complexed  to methylated bovine 
serum  albumin; GAT-SRBC,  GAT coupled  to  sheep  red  blood  cells;  GAT-T~F, GAT-specific 
suppressor T-cell factor; PBS, phosphate-buffered saline; PFC, plaque-forming cell(s); S~o units/ 
ml, inverse of dilution of extract that causes 50% suppression of a PFC response; Ts, suppressor T 
cell(s). 
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determined,  and its avidity for the antigen was compared with the avidity of 
anti-GAT antibodies produced in the same murine strain after immunization 
with GAT-MBSA.  Second,  the optimal conditions for the elution of GAT-T~F 
from  GAT-Sepharose  columns  to which  it  has  been  specifically  bound were 
defined, and the properties of this partially purified factor were compared with 
those of crude GAT-T~F. 
Materials and Methods 
Mice.  DBA/1 (H-2  '~) mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. 
BALB/c (H-2 '~) mice were obtained from the Health Research Laboratories, Buffalo, N. Y. Mice 
used  in  these  studies  were  from  2  to  8-mo  old  and  were  maintained on  acidified-chlorinated 
drinking water and laboratory chow ad libitum. 
Antigens.  The polymers of L-glutamic acid6°-L-alanine3°-L-tyrosine  ~° (GAT), L-glutamic acid  '~°- 
L-tyrosine  '~° (GT), and L-glutamic acid6°-L-alanine  4° (GA) were purchased from Miles Laboratories, 
Miles Research Division, Elkhart, Ind. Preparation of GAT-MBSA (1) and GT-MBSA (9) has been 
described. 
Preparation  of GAT  Suppressive Extract.  DBA/1  mice  received  10  t~g  of GAT  in  Maalox 
(William H. Rorer, Inc., Fort Washington, Pa.) i.p. 3 days before sacrifice. Single cell suspensions 
were prepared from spleen and thymus, adjusted to 6  ×  108 cells/ml, and sonicated as described 
previously (5, 6). Control extracts were prepared from the spleen and thymus of mice injected with 
Maalox alone. For the preparation of the GT factor, BALB/c mice were immunized i.p. with 100 tLg 
of GT in Maalos  (William H.  Rorer, Inc.).  3 days later the cell-free extract was prepared from 
spleen and thymus (7). 
Assay of the GAT-T,F.  For the in vivo assay of GAT-T~F, DBA/1 mice were injected i.v. with 
0.5 ml of various dilutions (1:2, 1:4, and 1:8) of the cell-free extract. The same day, each animal 
received  10  tLg of GAT  as  GAT-MBSA in  Maalox  and pertussis  vaccine  (Eli  Lilly  Company, 
Indianapolis, Ind.) i.p. 7 days later, the splenic GAT-specific IgG PFC responses were determined 
using GAT-SRBC as indicator cells in a  modified Jerne hemolytic plaque assay (1, 5). 
For the in vitro assay of GAT-T,F, replicate 1-ml cultures containing 8  ×  l0  G  spleen cells were 
established according to the modifications of the Mishell-Dutton system used in our laboratory (8), 
and dilutions of GAT-T~F and 10 t~g GAT as GAT-MBSA or SRBC were added at initiation. The 
IgG PRC  responses  were  measured  5  days  later.  As shown by the  cell recovery,  the cell-free 
extracts were toxic and suppressed both GAT-MBSA and SRBC response at dilutions below (1/200) 
(5). Therefore, higher dilutions of the extracts were routinely tested and this activity expressed as 
S.~ units/ml as previously described (6).  The GT suppressive factor was assayed only in vivo in 
BALB/c mice.  The animals were  injected i.v.  with  0.5  ml of various dilutions of the cell-free 
extract. On the same day, the animals received 10 t~g of GT as GT-MBSA emulsified with an equal 
volume of complete Freund's adjuvant (CFA) (Difco Laboratories, Detroit, Mich.) i.p. 7 days later 
the IgG PFC responses were determined using GAT-SRBC as indicator cells (9). 
Antisera.  The different anti-H-2  ~ sera were prepared by Dr.  Martin Dorf.  Anti-H-2  q serum 
was from D1.LP mice immunized with DBA/1 lymphoid cells; anti-D  ~ serum was from (C3H  × 
B10.D2) F~ mice immunized with B10.AKM cells. Anti-K  q + I" was from (DBA/2 × B10.BR)F~ mice 
immunized with B10.T (6R) cells, and an anti-K" serum was prepared in (C57BL/10SN × A/WY)F~ 
mice by immunization with B10.AQR cells. All sera were collected after six or more immuniza- 
tions; mice were bled individually, and the high-titered sera were pooled. Before use, the sera were 
absorbed for 1 h  at 4°C with thymocytes (108 cells/ml) from mice of the strain used to produce the 
antiserum. 
Anti-mouse Ig serum was obtained from rabbits that received multiple subcutaneous injections 
of 1  to  2  mg of purified  mouse Ig  emulsified in  CFA  IDifco  laboratories).  The hyperimmune 
antiserum used was analyzed for precipitating antibodies by double gel diffusion against purified 
myeloma proteins. This serum contained antibodies specific for tL, ~/1, ~2~, ~/2b, and a-heavy chains 
and K-light chain. The antibodies were purified by adsorption to CnBr-activated Sepharose 4B 
(Pharmacia Fine Chemicals, Piscataway, N. J.) to which mouse Ig has been coupled, according to 
the  manufacturer's  directions.  The  adsorbed  antibody  was  eluted  with  glycine-HC1,  pH  2.8, 
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Rabbit  anti-GAT  serum  was  obtained  from  rabbits  7  days  after  the  second  subcutaneous 
immunization with 1 mg GAT in CFA. DBA/1 anti-GAT serum was prepared by i.p. injection of 
male DBA/1 mice with 10 ~g GAT as GAT-MBSA in CFA four times at 2-wk intervals. 10 wk later, 
the mice received a single i.p. injection of GAT-MBSA in Maalox and were bled after 2 wk. The 
anti-GAT titer of these antisera was measured by hemagglutination using GAT-SRBC as indica- 
tor cells. 
Preparation of the Immunoadsorbents.  All sera were heat-inactivated at 56°C for 30 min, and 
the  globulin  fractions  of the  different  sera  were  prepared  by  precipitation  with  either  50% 
ammonium  sulfate or  18%  sodium  sulfate.  The precipitates  were dissolved in and  extensively 
dialyzed against 0.1 M NaHCO3 containing 0.5 M NaC1 (coupling buffer), and putative aggregates 
were removed by centrifugation at 15,000 g  for 30 min. 
The globulin  fractions  of rabbit  anti-mouse  Ig,  rabbit  anti-GAT,  and  the four alloantisera 
against different subregions of the H-2  ~ complex were coupled to Cnbr-activated Sepharose 4B by 
mixing the activated Sepharose beads with the dialyzed globulin fraction in coupling buffer for 2 
hr.  Unbound material was removed by washing with coupling buffer, and the remaining active 
groups were inactivated by overnight reaction at 4°C with 1 M ethanolamine  (pH 8). Noncova- 
lently adsorbed protein was removed by three washing cycles of 0.1 M acetate buffer containing 1 
M NaC1 (pH 4) followed by 0.1 M borate buffer containing 1 M NaC1  (pH 8).  The coupled beads 
were stored at 4°C in phosphate-buffer saline (PBS) containing 0.02% NAN3. 
The efficiency of the coupling was determined by measuring the optical density at 280 nm of the 
original  globulin  fraction  and  the  wash  fluids.  A  coupling  efficiency of 80-95%  was  usually 
obtained.  The amount of globulin attached to the Sepharose was calculated using an extinction 
coefficient ofE~m =  15, and the coupling conditions were adjusted to obtain 2 mg of protein per ml 
of packed $epharose. 
Radioactive Labeling of  the Antigens.  GAT, GT, and BSA were labeled with ~2'~I  (New England 
Nuclear, Boston, Mass.) using the chloramine T method (10). Since GA does not contain tyrosine, 
it was labeled with [~4C]methylamine as follows: 2 mg of GA0 0.31 mg of cold methylamine, 20 ~Ci 
of [14C]methylamine  (New England  Nuclear),  and  3  mg of 1-ethyl-3  (3-dimethylamino propyl) 
carbodiimide (ECDI) were dissolved in 1 ml of water. The pH was adjusted to 5.5,  and the mixture 
was reacted at room temperature for 4 h with stirring. The free methylamine was separated from 
the GA-bound radioactivity by passing the mixture through  a  Sephadex G-25 column and then 
dialyzing the excluded radioactivated material against PBS.  100% of the recovered radioactivity 
was precipitable by 20% trichloroacetic acid, and approximately 25% of the glutamic acid residues 
in the GA molecule were conjugated. 
Coupling of GAT, GT, GA, and BSA to Sepharsoe 4B.  GAT, GT, GA, and BSA were coupled 
individually to either amino ethyl-Sepharose 4B or to amino hexyl-Sepharose 4B (Pharmacia Fine 
Chemicals). The amino ethyl-Sepharose was prepared according to the method of Cuatrecasas (11). 
The amino-hexyl-Sepharose (commercial name AH-Sepharose) was obtained from Pharmacia Fine 
Chemicals. The antigens were dissolved in water and then coupled to the beads using ECDI. The 
pH was'carefully maintained at 7.5 in mixtures containing GAT and GT to avoid precipitation of 
these polymers at acid pH. The mixtures were rotated end-over-end for 18 h at room temperature. 
The antigens employed had been trace-labeled (see above), and after the coupling procedure, the 
beads were washed extensively with PBS until no radioactivity could be detected in the eluates. 
The amount of antigen bound was estimated by the amount of radioactivity bound to the beads. 
The conditions of the coupling were empirically adjusted such that 1-2 mg of antigen were coupled 
per ml of packed Sepharose.  The specific activity of the radiolabeled antigens was such that the 
leakage of 0.1 ~g of antigen could have been detected except for GA-Sepharose where leakage of a 
minimum of 0.5 ~g would have been detectable. 
Use of  Immunoadsorbent  Columns.  The immunoadsorbent columns were prepared by pack- 
ing required quantities of beads into barrels of 3- or 5-ml syringes. The beads were washed with 20 
ml PBS, then with 20 ml PBS containing 10% fetal calf serum, and finally the excess fetal calf 
serum  was removed with a  10 ml PBS wash.  The quantities  of wash solutions given are for a 
column of 1 ml of packed beads. The cell extract appropriately diluted in PBS, was applied to the 
column, reacted at 4°C for different periods of time (1-3 h depending on the experiment), and then 
eluted with PBS. Various dilutions of the eluates were then assayed in vivo or in vitro on the GAT- 
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Treatment with DNase, RNase, and Pronase.  DNase (2,700 U/mg, RNase free) was obtained 
from Worthington Biochemical Corp., Freehold, N. J., RNase (90 U/mg) from Sigma Chemical 
Co., St. Louis, Mo., and pronase (45,000 PUK) from Calbiochem, La Jolla, Calif. 1-ml portions of 
GAT-TsF were incubated with 200 ~g DNase, RNase, or pronase for 1 or 3 h at room temperature. 
The treated  GAT-TsF were  assayed  immediately for  suppressive  activity on  the  GAT-MBSA 
responses by DBA/1 mice in vivo. 
Purification of the GAT-T,F.  GAT-Sepharose was prewashed with 3 M KC1 in half strength 
PBS (PBS/2). Repeate'd testing revealed no detectable "leakage" of GAT from the column during 
both washing and actual elution of the factor. 
GAT-TsF was diluted 1/5 in PBS/2 and passed 3-4 times very slowly (1 ml/h) through the GAT- 
Sepharose. The column was then washed with 10 ml of PBS/2 per ml of packed beads. For the one- 
step elution, 2 M  KC1 in PBS was then applied to the beads,  and 3-5 times the volume of the 
column was used to elute the suppressive material. Elution by a continuous linear KC1 gradient 
was performed as follows: the gradient was prepared using 10 ml each of two solutions of PBS 
containing 0.25 M or 2 M KC1. During the elution the flow rate was 5 ml/h, and 7-ml fractions were 
collected. The KC1 concentration of each fraction was determined by measuring the refractive 
index, and the KC1 was removed by gel filtration on Sephadex G-25 using cytochrome C1 mg/ml) as 
a  marker.  The purified GAT-T~F was assayed in vitro on the response by DBA/1 spleen cells to 
GAT-MBSA (5, 6). 
Elution of  Rabbit and DBA /1 Anti-GAT Antibodies from GA T-Sepharose.  The GAT-Sepharose 
columns were prepared as above and anti-GAT antiserum (0.5 ml) was reacted for 1 h at 4°C with 2 
ml of packed  beads.  The antibodies were then eluted  with the linear KC1  gradient.  The KC1 
concentration of each fraction was measured, and then the KC1 was removed by gel filtration on a 
Sephadex  G-25  column using cytochrome c  (1  mg/ml) as  a  marker.  The titer of the anti-GAT 
antibodies in the original sera and in each fraction was determined by hemagglutination using 
GAT-SRBC as indicator cells. 
Gel Filtration on Sephadex G-IO0.  The molecular weight of the purified GAT-TsF was esti- 
mated by gel filtration on a Sephadex G-100 column (diameter 1.5 cm, length 90 cm) equilibrated 
at 4°C in PBS. A constant flow rate of 6 ml/h was used. Before use, the column was calibrated with 
the following protein markers: bovine gamma globulin (mol wt 150,000),  bovine serum albumin 
(mol wt 65,000),  ovalbumin (mol wt 45,000), bovine pancreas chymotrypsinogen A (mol wt 25,000), 
and horse heart cytochrome c (mol wt 12,500). GAT-TsF was purified by one-step elution from the 
GAT-Sepharose column with 2 M KC1,  and 0.5 ml of eluate was mixed with 0.5 ml of a  control 
extract from nonimmunized DBA/1 mice. This mixture was applied to the Sephadex G-100 column 
and eluted with PBS.  Fractions were pooled according to the desired molecular weight ranges 
determined by the previous calibration. The fractions were tested in vitro without concentration. 
The volumes of the fractions were measured and, for comparative purposes,  the dilutions of the 
suppressive factor in the various fractions were arbitrarily calculated as if all the original activity 
had eluted in that fraction. 
Results 
GAT-T,F Activity  is  Destroyed  by  Pronase.  GAT-TsF  was  treated  with 
DNase, RNase, or pronase and injected into mice that were immunized with 10 
fig of GAT as GAT-MBSA in Maalox-pertussis on the same day. Two represent- 
ative experiments are shown in Table I. Incubation with DNase and RNase for 1 
h  did  not  affect significantly  the  suppressive  activity  of GAT-TsF,  whereas 
incubation with pronase reduced it considerably. The reduction of activity was a 
time-dependent phenomenon,  as shown when the extract was incubated for 3 h 
with pronase  (Exp.  2). The GAT-TsF activity was completely destroyed under 
these conditions. 
GAT-T~F has Affinity for GAT.  Using an in vivo assay, we have previously 
demonstrated that GAT-T~F binds to GAT-Sepharose, but not BSA-Sephavose 
(5). We have repeated this experiment and quantitated the suppressive activity 
in vitro.  The activity (S~o units/ml)  of a  GAT-T~F was determined before and J.  THEZE,  J.  A.  KAPP,  AND  B.  BENACERRAF 
TABLE  I 
Effect of DNase, RNase, and Pronase on GAT-TsF 
843 
Time of  Percent 
IgG PFC/Spleen  inhibi-  P value§  Groups*  Enzyme  treat-  (arith. mean -+ SE) 
ment  tion$ 
Exp. 1 
Exp. 2 
% 
A  -  -  9,700 _+ 1,500 
B  None  1 h  700 _+ 700  93 
C  DNase  1 h  1,300  _+ 510  87  0.474 
D  RNase  1 h  2,100  _+ 790  78  0.240 
E  Pronase  1 h  4,500  -+ 1,300  54  0.043 
F  -  5,200 _  960 
G  None  3 h  1,300  _  1,050  75 
H  Pronase  3 h  5,200  _+ 580  0  0.01 
* DBA/1 mice received 0.5 ml of 1/2 dilution of GAT-TsF intravenously either untreated or treated 
with enzymes as indicated.  The mice were immunized with GAT-MBSA in Maalox-pertussis, 
and 7 days later the GAT-specific IgG PFC/spleen  was determined.  All groups contained  four 
animals except group G which contained three animals. Group A and F did not receive extracts 
and served as controls. 
[PFC/spleen for experimental] 
$ Percent inhibition  = 1 -  [  ~f~r~  J  × 100. 
§ P  value determined by Student's t test comparing all experimental groups to suppression  by 
untreated extract. 
after passage over BSA- or GAT-Sepharose column. 1 ml of extract from 6  ×  l0  s 
cells was  applied to columns containing  2  ml  of either packed  GAT- or BSA- 
Sepharose. These mixtures were reacted for 1 h  at 4°C, the extracts were eluted 
with PBS, and the eluates assayed in vitro. As shown in Fig.  1, BSA-Sepharose 
did not remove any GAT-TsF activity. In contrast,  GAT-Sepharose removed all 
detectable suppressive activity. These results confirm that GAT-TsF has affinity 
for GAT. 
Fine Specificity of the GAT-TsF.  The avidity of GAT-TsF for antigens that 
cross-react serologically with GAT [the copolymers of L-glutamic acid-L-alanine 
(GA) and L-glutamic acid-L-tyrosine (GT)] was determined to provide an indica- 
tion of the fine specificity of the GAT-T~F. 
1-ml samples of crude extract from spleen and thymus of GAT-primed DBA/1 
mice were reacted for 1 h  at 4°C  with  3 ml of GAT-Sepharose,  GT-Sepharose, 
GA-Sepharose,  or BSA-Sepharose.  The material eluted by PBS was tested for 
suppressive activity in vivo by injecting DBA/1 mice with 0.5 ml of the eluates, 
i.v.,  a  dose that was equivalent to a  1/2 dilution  of the original material.  The 
same day, mice were injected i.p. with 10 ~g of GAT as GAT-MBSA in Maalox- 
pertussis,  and  7  days later  the  splenic  GAT-specific IgG PFC  responses were 
measured. 
The  untreated  extract  suppressed the  response to  GAT-MBSA in  vivo in  a 
dose-dependent manner, a  1/8 dilution of the extract suppressed the GAT-MBSA 
response by only 29% (Fig. 2). All detectable suppressive activity was absorbed 
by GAT-Sepharose (group E). The activity of the extract was reduced,  but not 
totally absorbed by GT-Sepharose (group F) or GA-Sepharose (group G).  Com- 
parison  of the  suppressive  activity  in  the  eluate  from  GAT-Sepharose  with 844  IMMUNOSUPPRESSIVF,  FACTOR(S)  FROM  NONRESPONDER  MICE 
IO0  ~ 
80 
~  60- 
~  20- 
1  -- 
200  400  800 
/NVERSE  F/NAL  D/LUT/ON EXTRACT 
Fro. I.  Absorption of GAT-TsF with OAT- or BSA-Sepharose. 1 ml of GAT-TsF was 
incubated 1 h at 4°C with 2 ml of GAT-Sepharose or BSA-Sepharose. The results  are 
expressed as  percent inhibition  of  the control  IgG PFC response to GAT-MBSA  in  vitro  by 
different  dilutions  of  the eluates  and of  the original  extract.  (©--©) Untreated extract; 
(O--Q) extract  adsorbed  on a BSA-Sepharose column; (l--l) extract  adsorbed  on a GAT- 
Sepharose column. 
)UP  EXTRACT  SpecificIgG  %  INHIBITION  GAT-MBSA RESPONSE 
nO extrocl  --  6860 ± 1470 
.o~e  I,,2  mo :~ 2oo  EX\\\\\\\\\\\\~,~X\\\XX\\X~ 
none  I/8  4800_+670 
GAT..sept  I/2  7000t1050  I 
GT-seph  112  4540~_550 
GA-,~,ph  I/2  4400~_550 
BSA-=~  /2  i6~t BSO  EX\\\\%~\\\\\\\\\\\\\X~ 
Fro.  2.  Specificity of GAT-TsF  for GAT-, GT-, and GA-Sepharose. The data are expressed 
as the arithmetic mean  _+  SE of the PFC response  of eight mice per group. P  values 
determined by Student's t test are: F:E = 0.051; G:E = 0.042; F:G = 0.865, 
eluates from GT-Sepharose and GA-Sepharose indicates that these differences 
are statistically significant (P =  0.051 and 0.042, respectively), 
Since the observed absorption patterns might be explained by differences in 
the  inherent  efficiency of the  antigen-coated  beads,  we  tested the  absorbing 
capacity  of these  gels  with  the  suppressive  factor obtained  from spleen  and J.  THEZE,  J.  A.  KAPP,  AND  B.  BENACERRAF  845 
EXTRACT 
;ROUP 
Treotment  Dilution 
A  no extroct  - 
B  none  I/2 
C  none  114 
D  none  I/8 
E  GAT-seph  I/2 
F  GT-seph  I/2 
G  GA-seph  I/2 
H  BSA-seph  I/2 
Specmfic IgG 
PFC/Spleen 
5600±820 
390+ 150 
1080~:480 
5500+ 1310 
4080,880 
6290±720 
1900,650 
:580+ 140 
% INHIBITION GT-MBSA RESPONSE 
o  2,o  4p,  icp 
~\\\\\\\\\\\\\\\\\\\\\\\x~ 
~\\\\\\\\\\\\\\\\\\\~ 
I 
I 
~\\\\\\\\\\\\\\\\N 
~\\\\\\\\\\\\\\\\\\\\\\\\~ 
Fro.  3.  Specificity of the GT suppressive factor for GT-,  GAT,  and GA-Sepharose. The 
data are expressed as the arithmetic mean _+ SE of the PFC response of nine mice/group. P 
values determined by Students' t test are: E:F =  0.071; G:F <  0.001; G:E =  0.067. 
thymus  of nonresponder  BALB/c mice  immunized  with  GT.  This  factor was 
shown in previous studies to suppress the GT-MBSA response of BALB/c mice, 
and to behave like GAT-TsF (7). The GT factor was passed through the various 
immunoadsorbents  and  the  eluates  assayed  on  the  GT-MBSA  response  by 
BALB/c  mice.  GT-Sepharose  removed  all  detectable  suppressive  activity, 
whereas  GAT-Sepharose  and  GA-Sepharose  removed  only  a  fraction  of this 
activity (Fig.  3).  However, the difference of absorptive efficiency between the 
two cross-reacting immunoadsorbents, GAT-Sepharose and GA-Sepharose, was 
appreciable  (P  =  0.067).  Clearly,  differential  absorption of an  extract by the 
homologous antigen-Sepharose  complex is not due to variation in efficiency of 
the immunoadsorbents. 
GAT-TsF is not Bound by an Anti-Ig Immunoadsorbent.  Inasmuch as GAT- 
TsF has binding sites for the GAT, it is important to investigate the relationship 
of this factor to mouse Ig. The rabbit anti-mouse Ig serum used for this purpose 
contained antibodies against/~, 71, 7=, 72b, a-heavy chains and K-light chains. 
We have not tested the antiserum for anti-h  or 8-chain activity. The globulin 
fraction of the rabbit anti-mouse Ig serum was coupled to Sepharose 4B, and the 
capacity  of this  immunoadsorbent  was  measured  with  an  anti-GAT  serum 
obtained from DBA/1 mice immunized with GAT-MBSA. 1 ml of a  1/25 dilution 
of this serum was passed over 1 ml of anti-mouse Ig-Sepharose, and the titers of 
anti-GAT antibodies in the serum and the eluate were assessed by hemaggluti- 
nation of GAT-SRBC (Table II). Anti-GAT antibodies were removed by the anti- 
mouse Ig column.  1 ml of a  1/10 dilution of GAT-TsF from DBA/1 mice was also 
passed over 1 ml of anti-mouse Ig-Sepharose, and the activity of the GAT-TsF in 
the original preparation and the eluate was titrated in vitro (Table II). Instead 
of a reduction in the $5o units/ml, a slight increase in suppressive activity in the 
eluate  was  observed  in  this  and  several  other  experiments.  In  spite  of its 
specificity for GAT, GAT-TsF does not bear determinants of the constant regions 
of the ft, 7, or a-heavy chains or K-light chain of mouse Ig and, therefore, is not a 
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TABL~ II 
Absorbtion  of Anti-GAT Antibodies and GAT-TsF by a Specific Rabbit Anti-Mouse 
Ig Column 
Treatment 
GAT-TsF -  $5o units/ml*  Anti-GAT antibody- 
HA units$ 
Percent  Percent  GAT-  GAT-  SRBC  recov-  SRBC  recov-  MBSA  SRBC  ery  ery 
%  % 
Unabsorbed  <200  860  -  5  400  - 
Absorbed on  normal  rabbit  Ig- 
Sepharose column 
<200  1,200  >100  ND§  400  100 
Absorbed on  rabbit  anti-mouse 
Ig-Sepharose column¶ 
<200  1,200  >100  ND  10  2.5 
* S~0 units/ml: inverse of dilution causing 50% suppression of  the immune response to GAT-MBSA 
in vitro. 
$ HA units: inverse of the highest dilution causing hemagglutination of GAT-SRBC. 
§ ND, not done. 
¶ Rabbit anti-Ig antiserum contained precipitating antibodies specific for mouse tt, 7, y2a, ~2b, and 
a-heavy chain and K-light chain as determined by double gel diffusion. 
GAT-TsF has Determinants Encoded by the I-Region of the H-2 Complex.  T- 
cell factors with  specific helper  or suppressor  activity for antibody responses 
have been shown to bear determinants encoded by the I region of the murine H-2 
complex (3,  4,  12,  13).  We, therefore,  investigated whether GAT-TsF obtained 
from DBA/1 mice bears determinants encoded by the I region of H-2  q. GAT-T~F 
(0.75  ml  of a  1/10  dilution)  was  reacted  for  3  h  at  4°C  with  1 ml  of packed 
Sepharose to which the globulin fraction of alloantisera against products of the 
subregions  of the H-2  q complex had  been coupled.  The  various  eluates  were 
assayed  in  vitro  for  GAT-TsF  activity  (Fig.  4).  The  suppressive  factor  was 
completely removed by an anti-H-2  ~ immunoadsorbent produced in D1.LP mice 
against  DBA/1 cells,  which differ only at the H-2  complex.  This  experiment, 
therefore, demonstrates that GAT-T~F  bears determinants  encoded by the H-2 
complex.  Further  mapping  of the  GAT-T~F  determinants  has  been  achieved 
using alloantisera against the K, D, and K  + I  subregions of the H-2  q complex. 
The  activity of the  DBA/1 GAT-T~F was also removed by immunoadsorbents 
specific  for determinants  of K  +  I  regions  of the H-2  q complex,  but  not by 
immunoadsorbents specific for only the K  or D  determinants.  We may, there- 
fore, conclude that the GAT-TsF from DBA/1 mice bears specificities encoded by 
the I  region of H-2  q. 
Association of Antigen with the GAT-TsF.  Since GAT-TsF has affinity for 
GAT (5) and is extracted from lymphoid cells of mice recently injected with GAT 
(6),  it would not be surprising  if GAT determinants  were associated with the 
active moiety of GAT-T~F.  To test this possibility, the capacity of a rabbit anti- 
GAT  immunoadsorbent  column  was  first  measured  to  verify that  anti-GAT 
antibodies had not been altered by the coupling process; 1 ml of packed anti-GAT 
Sepharose was able to bind 1 t~g of GAT. Then, 1 ml of a 1/10 dilution of GAT-T~F J.  THEZE,  J.  A.  KAPP,  AND  B.  BENACERRAF 
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FIG. 4.  Absorption  of the GAT-TsF on immunoadsorbents specific for products of subre- 
gions oftheH-2 complex. GAT-TsF (0.75 ml of a 1/10 dilution) was incubated 3 h at 4°C with 
1 ml of packed Sepharose  to which the globulin  fraction of the following alloantisera had 
been coupled: (A--A)anti-H-2  q (D1.LP anti-DBA/1J);  ([3---y]) anti-D q (C3H x B10.D2)F~ 
anti-B10.AKM; (O- - -©) anti-K  q + Iq (DBA/2J × B10.BR)F1 anti-B10.T (6R); (m--I) anti- 
K  q (C57BL/10SN × A/WY)F1 anti-B10.AQR; (@--O) unadsorbed  extract. The results are 
expressed as percent inhibition of the control IgG PFC response to GAT-MBSA in vitro by 
different dilutions  of the eluates and of the original extract. 
was  applied to  rabbit  anti-GAT-Sepharose or normal  rabbit  serum-Sepharose 
column,  incubated  for  1  h  at  4°C,  and  eluted  with  PBS.  In  three  typical 
experiments,  (Fig.  5  and  Table  HI),  the  S~o  units/ml  of the  GAT-TsF  was 
significantly decreased by passage through  the rabbit anti-GAT column,  indi- 
cating that GAT is associated with the active suppressive factor. 
Elution of the GAT-TsF from GAToSepharose.  In a preliminary experiment 
(data not shown), GAT-TsF was eluted from GAT-Sepharose by PBS containing 
3 M  KC1. The critical concentration of KC1 required to elute GAT-TsF was then 
determined using a  gradient of 0.25 M  to 2 M  KC1. A  crude extract containing 
the GAT-TsF was applied to a  GAT-Sepharose column. The column was repeat- 
edly washed (see Materials and Methods) until no material was detectable at 280 
nm,  the  KC1  gradient  was  applied,  and  fractions  of equal  volumes were  col- 
lected.  The titer of GAT-TsF ($5o units/ml)  and the  KC1 concentration  of each 
fraction were determined (Fig. 6). The GAT-T~F eluted as a single peak at 0.4 M 
to 0.6 M KC1. The crude extract enhanced the response to SRBC, but none of the 
fractions  (I-V) displayed this  activity  (data not shown).  None of the  fractions 
had detectable optical density at 280 nm. 848  IMMUNOSUPPRESSIVE  FACTOR(S) FROM  NONRESPONDER  MICE 
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FIG.  5.  Absorption of the GAT-%F on rabbit anti-GAT immunoadsorbent. 1 ml of a  1/10 
dilution of GAT-%F was incubated 1 h  with 2 ml of the rabbit anti-GAT-Sepharose. The 
results are expressed as percent inhibition of the control IgG PFC response to GAT-MBA in 
vitro by different dilutions of the eluates and of the original extract.  (0--0)  untreated 
extract; (©--O) extract absorbed on rabbit anti-GAT-Sepharose column. 
TABLE  III 
Absorption of the GAT-T~F on a Rabbit Anti-GAT-Sepharose Column 
Immunoadsorbents 
Experiment ]I $5o  Experiment III S.5o 
units/ml  units/ml 
GAT-  GAT- 
SRBC  SRBC  MBSA  MBSA 
Unabsorbed  <400  1,500  <400  >2,000 
Normal rabbit  Ig-Sepharose  <400  1,800  <400  1,300 
Rabbit anti-GAT Ig-Sepharose*  <400  570  <400  600 
* Rabbit anti-GAT was obtained 7 days after the second immunization with 1 mg of GATin CFA. 
The immunoadsorbent was able to bind 1 ~g of GAT per ml of packed beads. 
For  comparative  purposes,  DBA/1  anti-GAT-MBSA  and  rabbit  anti-GAT 
antibodies were absorbed to GAT-Sepharose  and  eluted with a  KC1  gradient. 
Most of the antibodies in the serum of DBA/1 mice immunized with GAT-MBSA 
eluted at a  concentration  of 0.5 M KC1  (Fig.  7).  In a  parallel  experiment  (not 
shown), rabbit anti-GAT  antibodies eluted at  1.2 ~M KC1,  indicating  that this 
method distinguished differences in avidity. 
These experiments demonstrate several important points: (a) The total activ- 
ity of the  purified  GAT-TsF  was considerably higher  than  the  activity of the 
crude extract that was applied to the colum; (b) GAT/TsF eluted by KC1 is very 
highly  purified,  since  a  crude  extract  containing  10 mg protein  per ml  after 
elution yields a fraction with considerably greater suppressive activity than in 
initial preparation and yet no detectable optical density at 280 rim; and (c) if the 
KC1 concentration required for elution of the DBA/1 anti-GAT  antibodies and 2500 
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Fro.  6.  Elution  of GAT-TsF from  GAT-Sepharose  by  a  KC1  gradient.  Fractions  were 
assayed for suppressive activity on IgG PFC responses to GAT-MBSA and SRBC in DBA/1 
spleen cultures. None of the fractions suppressed PFC responses to SRBC (not shown). The 
suppressive activity is expressed in S.~, units/ml. The concentration of KC1 in each fraction 
was determined by refractometry. 
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FIG.  7.  Elution  of DBA/1  anti-GAT-MBSA  antibodies  from  GAT-Sepharose  by  a  KCI 
gradient.  The serum was diluted 1/25 by the elution procedure,  and this was the lowest 
dilution tested by hemagglutination on SRBC. The concentration of KC1 in each fraction 
was determined by refractometry. 
the GAT-TsF from the GAT-Sepharose immunoadsorbent accurately reflects the 
strength  of interaction between these molecules and GAT, then GAT-TsF and 
anti-GAT antibodies have comparable avidities for the antigen. 
For routine purification of GAT-TsF a one-step elution with 2 M KC1 was used. 
Under  these  conditions,  the  degree  of purification  is  comparable  to  the  one 
obtained  by continuous  gradient  elution  since  no optical  density  is detected. 
However, the increased activity obtained by the one-step elution procedure was 
smaller and less reproducible than that observed using the linear gradient. The 
factor obtained by the one-step procedure will be referred to as "purified GAT- 
TsF." 
Elution of a Control Extract from  GAT-Sepharose Does Not Generate  Sup- 
pressive Activity.  This  experiment  was  designed  to  verify that  GAT  is  not 850  IMMUNOSUPPRESSIVE  FACTOR(S) FROM  NONRESPONDER  MICE 
TABLE  IV 
Elution of a Control Extract From GAT-Sepharose  Does Not 
Generate Suppressive  Activity 
$5o units/ml* 
SRBC  GAT-MBSA 
GAT-TsF  <400  1,200 
Extracts eluted from GAT- 
Sepharose (2 M KC1) 
GAT-T~F  <400  1,200 
Maalox extract  <400  <400 
GAT +  Maalox extracts  <400  <400 
* $5o units/ml = inverse of dilution causing 50%  suppression of the 
immune response in vitro. 
S Maalox extract to which 10  ~g GAT was added per ml undiluted 
extract and incubated 1 h at 4°C, before application  to a GAT-Sepha- 
rose column. 
responsible for the suppressive activity of purified GAT-TsF. It had been previ- 
ously demonstrated that addition of GAT (25 ~g/ml) to a crude extract obtained 
from Maalox-primed mice (Maalox extract) does not generate suppressive activ- 
ity  at  dilutions  of GAT-TsF  which  are  active  in  vitro  or  in  vivo  (6). The 
experiment in Table  IV  established that  a  Maalox extract does  not become 
suppressive when processed by the protocol used for the purification of GAT-TsF 
from GAT-Sepharose.  Since no leakage of GAT from GAT-Sepharose was de- 
tected by monitoring the  radioactivity of the  eluates,  we  conclude that  the 
suppressive activity in purified GAT-TsF cannot be attributed to the introduc- 
tion of free GAT from the absorbent. Furthermore, addition of 10 ~g GAT/ml of 
Maalox extract before purification does not generate suppressive activity in the 
eluate demonstrating, again, that the suppressive activity of GAT-TsF is not due 
to native GAT. 
The  Purified  GAT-T~F  Bears  H.2  Determinants.  Purified  GAT-T~F  was 
applied to an anti-H-2 q immunoadsorbent column. After reaction for 2 h at 4°C 
and  elution with  PBS,  the  recovered  material  was  assayed for  suppressive 
capacity in vitro  (Fig.  8).  The suppressive  material, purified on the basis of 
avidity for GAT-Sepharose, was removed by an anti-H-2  q immunoadsorbent. 
The purified GAT-T~F was titrated before and after passage through the anti-H- 
2  q column in two additional experiments. In both experiments, the $50 units/ml 
in the purified extract were significantly reduced after passage over the anti- 
H-2 q immunoadsorbent. 
Purified  GAT-Ts F  Is  Not Associated  with  GAT.  We have  observed that 
GAT-T~F was absorbed by rabbit anti-GAT Sepharose, demonstrating that the 
active moiety in the crude extract was bound to GAT or a serologically reactive 
fragment of GAT. The possibility that the suppressive activity in GAT-T~F can 
be attributed to native GAT has been eliminated (6). However, the possibility 
that GAT together with an antigen-specific/-region gene product plays a crucial 
role in the suppression of responses to GAT-MBSA must be considered. 
Therefore the next experiments determined whether GAT was also associated J.  THEZE~  J.  A.  KAPP~  AND  B.  BENACERRAF 
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Fla.  8.  Adsorption of the purified GAT-T,F on an anti-H-2  q immunoabsorbent. The KCI 
eluate from the GAT-Sepharose column was passed over a Sephadex G-25 column, a portion 
of this material was assayed for suppressor activity ([3- -  -[3), and 0.75 ml of that material 
(diluted 1/20 by the purification) was applied to 1 ml of the immunoabsorbent. After a  2-h 
incubation, the material was eluted with PBS and assayed for suppressor activity in vitro 
(o--o). 
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FIo.  9.  Binding  of the  GAT-TsF  by  an  anti-GAT  immunoadsorbent  before  and  after 
purification on GAT-Sepharose. The crude extract (0.75 ml of a  1/20 dilution) and purified 
GAT-T~F  (0.75  ml  of a  1/20  dilution)  were  incubated  2  h  with  1  ml  of the  anti-GAT- 
Sepharose. The columns were eluted with PBS and suppressive activity assayed in vitro. 
(O--Q)  Crude  extract;  (©- --©)  crude  extract  absorbed by rabbit anti-GAT-Sepharose; 
([3- -  -[]) purified GAT-TsF; (m--I) purified GAT-TsF absorbed by rabbit anti-GAT-Sepha- 
rose. Rabbit anti-GAT was obtained 7 days after secondary immunization with 1 mg of GAT 
in CFA. The immunoadsorbent was able to bind 1 ~g of GAT per ml of packed gel. 
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with the purified GAT-TsF. Purified GAT-TsF and a portion of the crude extract 
were  applied  to  rabbit  anti-GAT-Sepharose  columns,  and  the  eluates  were 
tested for suppressive activity in vitro (Fig. 9). As previously observed, the titer 
GAT-TsF in the crude material is reduced significantly by passage over the anti- 852  IMMUNOSUPPRESSIVE  FACTOR(S)  FROM  NONRESPONDER  MICE 
TABLE  V 
Purified GAT-T~F Is Not Associated  with Serologically  Detectable GAT Determinants 
Treatment of extract 
Experiment II $5o  Experiment III $5o 
units/ml  units/ml 
GAT-  GAT- 
SRBC  SRBC  MBSA  MBSA 
Crude GAT-TsF untreated  <400  1,300  500  2,000 
Crude GAT-TsF absorbed by rabbit 
anti-GAT-Sepharose* 
400  800  <400  <400 
Purified GAT-TsF  <400  3,300  <400  1,100 
Purified GAT-TsF absorbed by anti- 
GAT-Sepharose* 
<400  >3,200  <400  900 
* Rabbit anti-GAT was obtained 7 days after the second immunization with i  mg of GAT in CFA. 
The immunoadsorbent was able to bind 1 fig of GAT per m] of packed gel. 
GAT column. By contrast, the titer of the purified GAT-TsF was not detectably 
reduced by passage over rabbit anti-GAT-Sepharose. Two additional confirma- 
tory experiments in which the results are expressed in $5o units/ml are in Table 
V. Thus, GAT is not associated with purified GAT-T~F, and the GAT that was 
associated with GAT-T~F in the crude extract was displaced in the purification 
procedure. 
Estimation  of Molecular  Weight  of the  Purified  GAT  Suppressor  Fac- 
tor.  The molecular weight of the GAT-TsF activity in the crude extract has 
been estimated to be approximately 45,000, both by gel filtration on Sephadex G- 
100 and ultrafiltration through Amicon membranes (5). However, for unknown 
reasons, the suppressive activity eluted in a broad band from Sephadex. There- 
fore,  purified GAT-T~F was fractionated on  a  Sephadex G-100 column.  The 
majority of the suppressive activity was in fraction III (mol wt 40,000-55,000) 
(Table VI). Fractions IV and V had much smaller, but detectable, amounts of 
activity; fraction I, which corresponds to the void volume of the column (mot wt 
>80,000), had no detectable activity, and fraction II (mol wt 55,000-80,000) had 
very little activity. 
Discussion 
Some of the properties of GAT-TsF, an extract of lymphoid cells from GAT- 
primed nonresponder DBA/1 mice, have been analyzed. GAT-TsF is a protein 
that has affinity for GAT.  Despite its affinity for the stimulating antigen, the 
active factor does not bear /z, T1, T2~, T2b, or a-heavy chain or K-light  chain 
constant region determinants. 
The fine specificities of GAT-TsF and of a  factor extracted from GT-primed 
BALB/c mice have been characterized by comparing the absorption of suppres- 
sive  activity by  columns containing homologous or  chemically related and 
serologically cross-reactive insolubilized copolymers. The results demonstrated 
that  these  factors bind  preferentially to  the  antigen  that  stimulated their 
production, but that binding to cross-reactive antigens is comparable to that of J.  THEZE,  J.  A.  KAPP,  AND  B.  BENACERRAF 
TABLE  VI 
Estimate of the Molecular Weight of Purified GAT-T~F by Gel 
Filtration on Sephadex G-I O0 
Sso units/ml 
SRBC  GAT-MBSA 
Crude GAT-TsF  <400  1,200 
Purified GAT-TsF  <400  >1,600 
Purified GAT-TsF eluted from 
Sephadex G-100* 
Fraction I  <400  <400 
Fraction II  <400  400 
Fraction III  <400  >1,600 
Fraction IV  <400  800 
Fraction V  <400  600 
* The size of the molecules eluted in the different fractions is: Fraction I, 
>80,000; Fraction II, 55,000-80,000;  Fraction IU, 40,000-55,000;  Frac- 
tion IV,  20,000-40,000;  Fraction  V,  <20,000.  The column  was  cali- 
brated with bovine gamma globulin (150,000),  bovine serum albumin 
(65,000),  ovalbumin  (45,000),  bovine pancreas  chymotrypsinogen  A 
(25,000),  and horse heart cytochrome c  (12,500). 
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antibodies produced in the same strain of mice. Based on the assumption that 
the concentration of KC1 required to dissociate a factor bound to an insolubilized 
antigen is an estimate of avidity, the relative avidities of GAT-T~F and anti= 
GAT antibodies produced in DBAJ1 mice were compared. Both GAT-T~F and 
anti-GAT antibodies from DBA/1 mice were eluted with approximately 0.5 M 
KC1, whereas rabbit anti-GAT antibodies were eluted with 1.2 M KC1. There- 
fore, on the basis of specificity and avidity, GAT-T~F resembles the anti-GAT 
antibodies produced by the same strain.  However, GAT-T~F is much smaller 
than immunoglobulin (5) and does not bear constant region determinants of 
heavy or light chains. The interesting possibility that GAT-T~F  shares idiotypic 
determinants with anti-GAT antibodies is currently under investigation. 
When GAT-T~F was eluted from GAT-Sepharose by a KC1 gradient, the total 
suppressive activity obtained was much greater than that in the crude extract. 
Three observations must be considered to explain this difference. First, extracts 
of lymphoid cells from control mice routinely enhance the PFC  responses in 
cultures stimulated with either GAT-MBSA or SRBC.  Second, extracts from 
GAT-primed mice enhance responses to SRBC in vitro. Finally, this nonspecific 
enhancing activity was not detected in the fractions of GAT-T~F eluted from 
GAT-Sepharose by KC1  gradients.  Therefore, GAT-T~F activity in the crude 
extracts appears to be partially masked by the nonspeciiic enhancing factors. 
The nature of these enhancing factors is unknown, but since these extracts do 
not enhance immune responses in vivo,  they may act to improve the culture 
conditions in a nonimmunological manner. 
Similar to the suppressor factor described by Tada and Tanaguchi (3, 4), GAT- 
TsF possesses determinants encoded by the I region of  the H-2 complex. Further- 
more, purified GAT-TsF was absorbed by insolubilized anti-H-2  Q  sera (Fig.  8), 
conchlsively demonstrating that  the  same  molecule (or  molecular complex) 
possesses a combining site(s) for GAT as well as determinants encoded by the I 854  IMMUNOSUPPRESSIVE  FACTOR(S)  FROM  NONRESPONDER  MICE 
region of the H-2  complex. The KLH-specific suppressor factor of Tada and 
associates has been reported to bear determinants controlled by the I-J subre- 
gion of the H-2 complex (14). Further serologic and genetic analysis of GAT-TsF 
from DBA/1 mice is currently prevented by the lack of appropriate recombinant 
strains. 
The GAT-TsF activity in the crude extracts could be absorbed by an immuno- 
adsorbent containing anti-GAT antibodies, indicating that at least a fragment of 
antigen is associated with this suppressive factor. This finding is not surprising 
since GAT-TsF has binding sites for the antigen, and the mice from which the 
factor is extracted received 10 ~g of GAT only 3 days before the preparation of 
the celt-free extract. However, the presence of antigen in the KLH suppressor 
factor has not been reported by Tada and associates (3, 4, 14). 
The demonstration of GAT associated with the active suppressive factor and 
the ease with which suppressor T cells are stimulated by GAT in nonresponder 
DBA/1 mice (1, 2) raised the issue of whether sufficient native antigen is present 
in the crude lymphoid cell extracts from GAT-primed mice to cause suppression 
itself. To test this possibility, an amount of GAT equivalent to that injected into 
donor mice was added to extracts from Maalox-primed animals. These control 
extracts containing GAT were tested in vivo and in vitro, and no significant 
suppression  was  detected at  dilutions  where GAT-TsF  was  suppressive  (6). 
Therefore,  it  is  clear  that  the  amount of GAT  associated  with  the  active 
suppressor extract is by itself insufficient to cause the suppression. In addition, 
the demonstration that the active factor bears Ia determinants and has antigen- 
binding specificity for GAT further indicates that it is not simply native or 
unprocessed GAT.  Nevertheless, the possibility must be considered that GAT 
together  with  an  antigen-specific /-region  product  plays  a  crucial  role  in 
suppression of  the responses to GAT-MBSA. If  this were the case, associations of 
an/-region product with  native or processed GAT  must result  in  a  highly 
suppressive  form  of GAT.  In  contrast to  the  suppressive  activity of crude 
extracts, purified GAT-TsF was not absorbed by an anti-GAT-Sepharose col- 
umn. This suggests that the antigen-GAT-T~F complex in the crude extract was 
dissociated during the purification. The observation that the purified GAT-T~F 
is not associated with GAT does not establish that antigen is unnecessary  for its 
suppressive activity since the assay for activity requires the presence of GAT- 
MBSA. The factor could readily bind to GAT and, in fact, may have to bind to 
antigen  in  order to  exert  is  specific  suppressive  effect.  The  availability of 
antigen-free purified GAT-T~F should allow the determination of the role of 
antigen-factor interactions in the inhibition of responses to GAT-MBSA.  Fur- 
thermore, the methodology described in these papers should also permit the 
preparation and isolation of GAT-T~F from primed T cells in amounts sufficient 
for molecular characterization by classical biochemical techniques. 
The experiments reported in this paper establish that GAT-T~F belongs to the 
same class of immunosuppressive molecules described by Tada et al.  (3, 4,  14) 
and Herzenberg et al.  (15). These mediators resemble a helper T-cell replacing 
factor described by Mozes (13) and Taussig et al.  (16). Thus, it appears that a 
new family of regulatory proteins have been described that are physically and 
immunologically similar, antigen-specific, but of opposing activities. J. THEZE,  J. A.  KAPP,  AND  B.  BENACERRAF  855 
Summary 
The GAT-specific  suppressor  T-cell  factor  (GAT-TsF) extracted  from  lymphoid 
cells  from GAT-primed, nonresponder  DBA/1 mice  has  been  partially  character- 
ized.  It  is  a protein  that  has affinity  for  GAT and  determinants  encoded  by  the  I 
region of  the  H-2 complex. 
On the basis  of  specificity  and avidity,  GAT-TsF resembles anti-GAT-MBSA 
antibodies  produced by DBA/1 mice in  spite  of  the  fact  that  it  is  too  small  to  be 
classical  antibody and has no constant-region  determinants of  heavy or light 
chains.  Further,  GAT or  a fragment of  GAT is  associated  with  the GAT-TsF. 
GAT-TsF has been partially  purified  from the crude extract  by absorption  to 
GAT-Sepharose and  elution  with  0.4  to  0.6  KCI. GAT-TsF purified  on  the  basis  of 
its  affinity  for  GAT bears/-region  determinants  but  not  detectable  GAT or  GAT 
fragment. 
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